Recombinant single-chain anti-idiotypic antibody: An effective fungal β-1,3-glucan synthase inhibitor

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 9, 2006, Pages 1848-1853

  Selvakumar, Dakshnamurthy ^a   Karim, Nurul ^a   Miyamoto, Masahiko ^a   Furuichi, Yasuhiro ^b   Komiyama, Tadazumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b GeneCare Research Institute   (Japan)

Author keywords

1,3 glucan synthase; Anti fungal antibiotic; Candida albicans; Cryptococcus albidus; Recombinant anti idiotypic antibody; Saccharomyces cerevisiae

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; ACULEACIN A; PAPULACANDIN B; RECOMBINANT ANTI IDIOTYPIC ANTIBODY; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CRYPTOCOCCUS; DRUG ACTIVITY; ENZYME INHIBITION; IC 50; NONHUMAN; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANTIBIOTICS, ANTIFUNGAL; ANTIBODIES, ANTI-IDIOTYPIC; ANTIFUNGAL AGENTS; BETA-GLUCANS; GLUCOSYLTRANSFERASES; IMMUNOGLOBULIN FRAGMENTS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS;

EID: 33748372772     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1848     Document Type: Article

References (40)

1. Gordee R. S., Debono M., Parr T. R., "New Approaches for Anti-fungal Drugs," ed. by Frenandes P. B., Birkhauser Press, Boston, 1992.
2. Tracz J. J., "Emerging Targets in Antimicrobial and Antifungal Chemotherapy," ed. by Sutcliffe J. A., Shadomy H. J., Chapman and Hall Ltd., London, 1992.
3. Ruiz-Herrera J., "Fungal Cell Wall: Structure, Synthesis, and Assembly," CRC Press, Inc., Boca Raton, Florida, 1992.
4. Yamamoto T., Hiratani T., Hirata H., Imai M., Yamaguchi H., FEBS Lett., 197, 50-54 (1986).
5. Yamamoto T., Imai M., Tachibana K., Mayumi M., FEBS Lett., 195, 253-257 (1986).
6. Komiyama T., Ohta T., Urakami H., Shiratori Y., Takasuka T., Sato M., Watanabe T., Furuichi Y., J. Biochem. (Tokyo), 119, 731-736 (1996).
7. Kasahara S., Ben I. S., Mio T., Yamada T., Nakajima T., Ichishima E., FEBS Lett., 348, 27-32 (1994).
8. Takasuka T., Komiyama T., Furuichi Y., Watanabe T., Cell Mol. Biol. Res., 41, 575-581 (1995).
9. Myskowski P. L., White M. H., Ahkami R., Dermatol. Clin., 15, 295-305 (1997).
10. Karlowsky J. A., Zhanel G. G., Klym K. A., Hoban D. J., Kabani A. M., Diagn. Microbiol. Infect. Dis., 29, 5-9 (1996).
11. Ponikau J. U., Sherries D. A., Kern E. B., Mayo Clin. Proc., 74, 877-884 (1999).
12. Rogers A. L., Kennedy M. J., "Manual of Clinical Microbiology," 5th ed., ed. by Balows A., Hausler W. J., Herrmann K. L., Isenberg H. D., Shadomy H. J., American Society for Microbiology, Washington, D.C., 1991.
13. Warren N. G., Shadomy H. J., "Manual of Clinical Microbiology," 5th ed., ed. by Balows A., Hausler W. J., Herrmann K. L., Isenberg H. D., Shadomy H. J., American Society for Microbiology, Washington, D.C., 1991.
14. Mizuno K., Yagi A., Satoi S., Takada M., Hayashi M., J. Antibiot., 4, 297-302 (1977).
15. Traxler P., Fritz H., Richter W. J., Helv. Chim. Acta, 60, 578-584 (1977).
16. Debono M., Gordee R. S., Ann. Rev. Microbiol., 48, 471-497 (1994).
17. Komiyama T., Shirai T., Ohta T., Urakami H., Furuichi Y., Tsukada Y., Biol. Pharm. Bull., 21, 1013-1019 (1998).
18. Smith P. K., Krohn R. I., Hermanson G. T., Anal. Biochem., 150, 76-85 (1985).
19. Magliani W., Conti S., de Bernardis F., Gerloni M., Bertolotti D., Mozzoni P., Cassone A., Polonelli L., Nat. Biotechnol., 15, 155-158 (1997).
20. Cabib E., Kang M. S., "Methods Enzymology," Vol. 138, ed. by Ginsberg V., Academic Press, New York, 1987, pp. 637-642.
21. Yamamoto T., Uchida K., Hiratani T., Miyazaki T., Yagiu J., Yamaguchi H., J. Antibiot., 41, 398-403 (1988).
22. Loison J., Bouchara J. P., Gueho E., de Gentile L., Cimon B., Chennebault J. M., Chabasse D., J. Infect., 33, 139-140 (1996).
23. Kordossis T., Avlami A., Velegraki A., Stefanou I., Georgakopoulos G., Papalambrou C., Legakis N. J., Med. Mycol., 36, 335-339 (1998).
24. Ikeda R., Sugita T., Jacobson E. S., Shinoda T., Microbiol. Immunol., 47, 271-277 (2003).
25. Groll A. H., Walsh T. J., Clin. Microbiol. Infect. Dis., 7, 8-24 (2001).
26. Cabib E., Bowers B., Sburlati A., Silverman S. J., Microbiol. Sci., 5, 370-375 (1988).
27. Ruiz-Herrera J., Antonie Van Leeuwenhoek., 60, 72-81 (1991).
28. Goldman R. C., Frost D. J., Capobianco J. O., Kadam S., Rasmussen R. R., Abad-Zapatero C., Infect. Agents Dis., 4, 228-247 (1995).
29. Traxler P., Tosch W., Zak O., J. Antibiot., 40, 1146-1164 (1987).
30. Taft C. S., Selitrennikoff C. P., J. Antibiot., 43, 433-437 (1990).
31. Font D. E., Mora J., Herrero E., Sentandreu R., FEMS Microbiol. Lett., 111, 43-47 (1993).
32. Georgopapadakou N. H., Walsh T. J., Antimicrob. Agents Chemother., 40, 279-291 (1996).
33. Fostel J. M., Lartey P. A., Drug Discov. Today, 5, 25-32 (2000).
34. Onishi J., Meinz M., Thompson J., Curotto J., Dreikorn S., Rosenbach M., Douglas C., Abruzzo G., Flattery A., Kong L., Cabello A., Vicente F., Pelaez F., Diez M. T., Martin I., Bills G., Giacobbe R., Dombrowski A., Schwartz R., Morris S., Harris G., Tsipouras A., Wilson K., Kurtz M. B., Antimicrob. Agents Chemother., 44, 368-377 (2000).
35. Georgopapadakou N. H., Expert. Opin. Investig. Drugs, 10, 269-280 (2001).
36. Vazquez J. A., Clin. Ther., 27, 657-673 (2005).
37. Feldmesser M., Kress Y., Mednick A., Casadevall A., J. Infect. Dis., 182, 1791-1795 (2000).
38. Ernst E. J., Klepser M. E., Pfaller M. A., Antimicrob. Agents Chemother., 44, 1108-1101 (2000).
39. Serena C., Fernandez-Torres B., Pastor F. J., Trilles L., Lazera Mdos S., Nolard N., Guarro J., Antimicrob. Agents Chemother., 49, 2994-2996 (2005).
40. Selvakumar D., Miyamoto M., Furuichi Y., Komiyama T., J. Antibiot., 59, 73-79 (2006).